| European Leukemia Trial Registry |
| Trial: MDS Darbepoetin-Filgrastim |
| Title | Darbepoetin alpha and G-CSF vs. best supportive care |
| Scientific Title | A randomised controlled trial of prolonged treatment with darbepoetin alpha and recombinant human granulocyte colony stimulating factor (G-CSF) versus best supportive care in patients with low-risk myelodysplastic syndromes. |
| Short Title | MDS Darbepoetin-Filgrastim |
| Trialgroup | NN |
| Disease | Myelodysplastic Syndrome(MDS) All subtypes |
| Age | >= 18 years |
| Status | Active |
| Start of Recruitment | 13.06.2005 |
| Leader | Mufti, Prof. Dr. med., Ghulam Jeelani |
| Contactperson |
General Contact Person
General Contact Person
General Contact Person |
| Centre of Trial | King’s College Hospital; London, U.K. |
| Shortprotocol | Shortprotocol |
